Press release
Investigation over potential Wrongdoing announced for Investors who lost money with shares of DermTech, Inc. (NASDAQ: DMTK)
An investigation on behalf of investors in DermTech, Inc. (NASDAQ: DMTK) shares over possible breaches of fiduciary duty.
Investors who are current long term investors in DermTech, Inc. (NASDAQ: DMTK) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: DMTK stocks follows a lawsuit filed against DermTech, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: DMTK stocks, concerns whether certain DermTech, Inc. directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Southern District of California the plaintiff alleges that, the Defendants failed to disclose to investors that the Company experienced challenges with collections from commercial payors, that, as a result, there was a lower average selling price for DermTech's DMT, that, as a result of the foregoing, the Company's revenue growth would be adversely impacted, and that , as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Those who purchased shares of DermTech, Inc. (NASDAQ: DMTK) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation over potential Wrongdoing announced for Investors who lost money with shares of DermTech, Inc. (NASDAQ: DMTK) here
News-ID: 3542115 • Views: …
More Releases from Shareholders Foundation, Inc.
NASDAQ: REPL Investor Alert: Lawsuit against Replimune Group, Inc. seeks to reco …
An investor, who purchased shares of Replimune Group, Inc. (NASDAQ: REPL), filed a lawsuit over alleged violations of Federal Securities Laws by Replimune Group, Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Replimune Group, Inc. (NASDAQ: REPL) have certain options and for certain investors are short and strict deadlines running. Deadline: October 5, 2026. NASDAQ: REPL investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
NYSE: BMI Long Term Investor Alert: Investigation over potential Wrongdoing by c …
An investigation was announced for long-term investors in shares of Badger Meter, Inc. (NYSE: BMI) concerning potential breaches of fiduciary duties by certain directors of Badger Meter, Inc. was announced.
Investors who are current long term investors in Badger Meter, Inc. (NYSE: BMI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit Alert: Investors who lost money with ARS Pharmaceuticals, Inc. (NASDAQ: …
An investor, who purchased shares of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), filed a lawsuit over alleged violations of Federal Securities Laws by ARS Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) have certain options and for certain investors are short and strict deadlines running. Deadline: October 5, 2026. NASDAQ: SPRY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Investigation Alert: Investors in GeneDx Holdings Corp. (NASDAQ: WGS) should con …
An investigation was announced for current long-term investors in shares of GeneDx Holdings Corp. (NASDAQ: WGS) concerning potential breaches of fiduciary duties by certain directors and officers of GeneDx Holdings Corp.
Investors who are current long term investors in GeneDx Holdings Corp. (NASDAQ: WGS) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
More Releases for DermTech
Skin Imaging System Market Is Going to Boom | Canfield Scientific • DermTech â …
Coherent Market Insights has released a report titled "Skin Imaging System Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2026-2033", which includes market percentage records and a thorough enterprise analysis. This report looks at the market's competition, geographic distribution, and growth potential. This comprehensive report encompasses industry performance, critical success factors, risk assessment, manufacturing prerequisites, project expenses, economic analysis, anticipated return on investment (ROI), and profit margins.
➤ Get Sample…
Skin Cancer Diagnostics and Therapeutics Market Is Going to Boom |• DermTech â …
Worldwide Market Reports has added a new research study on "Skin Cancer Diagnostics and Therapeutics Market" is projected to experience substantial growth in the coming years. This report provides a comprehensive analysis of the market landscape using an integrated approach that includes research methodology, market size evaluation, data compilation, and insights gathered from multiple credible sources.
The study covers critical market elements such as market dynamics, drivers, restraints, challenges, threats, growth…
AI Skin Analysis Market - Massive Growth Opportunity Seen Ahead | SkinVision, De …
HTF MI just released the Global AI Skin Analysis Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major Giants in AI Skin Analysis Market are:
IBM Watson Health…
Deadline on Dec. 15th coming up in Lawsuit for Investors in DermTech, Inc. (NASD …
A deadline is coming up on December 15, 2023 in the lawsuit filed for certain investors of DermTech, Inc. (NASDAQ: DMTK) over alleged securities laws violations by DermTech, Inc.
Investors who purchased shares of DermTech, Inc. (NASDAQ: DMTK) have certain options and there are strict and short deadlines running. Deadline: December 15, 2023. NASDAQ: DMTK stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…
Lawsuit filed for certain Investors who lost money with shares of DermTech, Inc. …
An investor, who purchased shares of DermTech, Inc. (NASDAQ: DMTK), filed a lawsuit over alleged violations of Federal Securities Laws by DermTech, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of DermTech, Inc. (NASDAQ: DMTK) between May 3, 2022 and November 3, 2022, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2023. NASDAQ:…
Investigation announced for Investors in shares of DermTech, Inc. (NASDAQ: DMTK) …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at DermTech, Inc.
Investors who purchased shares of DermTech, Inc. (NASDAQ: DMTK) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain DermTech directors breached their fiduciary duties and caused damage to the company and its shareholders.
San Diego, CA based DermTech,…
